Project Grant K01DA060986
Award Date
6/1/25
Completion Date
5/31/30
Dollars Obligated
$174K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK, USA
Similar Awards
This $2,729,018 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and evaluate a mobile health intervention for individuals with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential treatment. The grant supports a ground-up approach to rigorously develop and evaluate a mobile app with both on-demand (24/7 PTSD-OUD...
This federal Project Grant award of $945,397 from the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs aims to adapt and evaluate a Collaborative Care Model (CCM) for providing integrated care to pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The grant will fund a two-phase study to: 1) adapt an existing CCM for rural and low-resource obstetric settings, and 2) evaluate the effects of the adapted CCM on MOUD...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $390,635 to the University of Pittsburgh to develop and test a novel intervention targeting prenatal depressive symptoms to encourage tobacco and cannabis cessation among marginalized pregnant and postpartum individuals. The key activities include: 1) Conducting formative research to contextualize the role of depressive symptoms in prenatal...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $193,550 to Boston Medical Center Corporation (BMC) over a 5-year period from February 1, 2025 to January 31, 2030. The funding will support the community-engaged development and pilot testing of a peer breastfeeding support intervention for mothers with opioid use disorder (OUD). The key objectives are to: 1) engage mothers with OUD to identify...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support an early career investigator's research to evaluate racial disparities in the use and effectiveness of medications to treat opioid use disorder (OUD) during pregnancy. The $196,236 award, spanning from August 1, 2024 to July 31, 2029, will enable the investigator to use a target trial emulation approach to assess how factors like racial...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is supporting the implementation and evaluation of a video-coaching intervention entitled "THRIVE" to promote positive parenting behaviors among mothers with opioid use disorder (OUD). The $193,752 grant aims to integrate this evidence-based parenting intervention into pediatric primary care settings, with the goal of improving parenting...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a $1,948,634 effort to adapt and test a smartphone-based mobile health (mHealth) intervention to reduce overdose risk among people who engage in polysubstance use. The key products and services to be delivered under this R61/R33 award include: In the R61 phase, the research team will work with people who use drugs, local harm reduction...
This Project Grant award, with a total funding amount of $958,629, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding will support the real-world adoption of an innovative digital health therapeutic called KIOS, which uses nonlinear control theory to track multiple symptoms (e.g., craving, mood, pain) and deliver personalized, evidence-based intervention strategies to patients with opioid use disorder...
This $311,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development and pilot testing of a novel mobile health (mHealth) intervention to reduce frequent and high-intensity cannabis use among young adults not attending college. The proposed "TAKE 5" intervention integrates online personalized feedback and tailored text messages to address five key domains related to cannabis use...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test a prototype mobile health application called R-ASSIST. The app is designed to support individuals released from jail who are recovering from co-occurring opioid use and mental health disorders. Key features of the R-ASSIST app include daily self-reported symptom and medication management monitoring, a self-help curriculum, a...